Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer

NCT02028494 is registered in ClinicalTrials.gov with Latin American & Caribbean Society of Medical Oncology as lead sponsor.

NCT NCT02028494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
Lead sponsor
Latin American & Caribbean Society of Medical Oncology
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2013
Completion date
March 31, 2019
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer